• OPEN AN ACCOUNT
Indian Indices
Sensex
72,269.69 676.45
( 0.94%)
Global Indices
Nasdaq
51,245.91 45.04
(0.09%)
Dow Jones
7,786.38 -36.39
(-0.47%)
Hang Seng
69,343.08 -692.63
(-0.99%)
Nikkei 225
10,441.54 -16.96
(-0.16%)
Forex
USD-INR
96.67 0.30
(0.31%)
EUR-INR
108.31 -0.02
(-0.02%)
GBP-INR
127.86 0.18
(0.14%)
JPY-INR
0.61 0.00
(0.24%)

EQUITY - MARKET SCREENER

BSE SENSEX Next 30
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
1189
N.A
0
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
24.57
0
EPS(TTM)
Face Value()
Div & Yield %
0
100
1.05
 

glaxosmithkline pharma ltd
Manugraph India reports standalone net loss of Rs 1.23 crore in the March 2026 quarter
May 20,2026
Net Loss of Manugraph India reported to Rs 1.23 crore in the quarter ended March 2026 as against net loss of Rs 1.15 crore during the previous quarter ended March 2025. Sales declined 10.17% to Rs 25.09 crore in the quarter ended March 2026 as against Rs 27.93 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 4.95 crore in the year ended March 2026 as against net loss of Rs 26.69 crore during the previous year ended March 2025. Sales rose 49.35% to Rs 88.64 crore in the year ended March 2026 as against Rs 59.35 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales25.0927.93 -10 88.6459.35 49
OPM %2.79-0.82 -7.96-20.79 -
PBDT0.61-0.64 LP 6.51-14.04 LP
PBT0.36-0.83 LP 5.67-14.83 LP
NP-1.23-1.15 -7 4.95-26.69 LP